Friedman Billings Resumes Coverage on Bed Bath & Beyond (BBBY)
More News related to BBBY
- Beacon Equity Issues Technical Trade Alerts on Recent Analyst Upgrades: PCL, ADI, BBBY, PAG, PGR, BTU
- David Moenning's Daily State of the Markets: 11/12
- Notable Analyst Rating Changes 11/12: BBBY, PAG, ROK Upgraded; EGLE, FMCN, BRCM Downgraded
- Goldman Sachs Upgrades Bed Bath & Beyond (BBBY) to Buy
- Bed Bath & Beyond (BBBY) President Sells 307K Shares
More News related to New Coverage
- Citi Initiates Coverage on US Soft Drink Makers
- William Blair Initiates Coverage on Data Networking Stocks
- Caris Starts Coverage on Ariba (ARBA), Concur (CNQR), salesforce.com (CRM), Taleo (TLEO)
- Oppenheimer Initiates Coverage on ViroPharma (VPHM)
- Oppenheimer Initiates Coverage on Cadence Pharmaceuticals (CADX) with an Outperform
Friedman Billings resumes coverage on Bed Bath & Beyond (Nasdaq: BBBY) with a Underperform rating. Price target $26.50.
Bed Bath & Beyond Inc. and subsidiaries is a chain of retail stores, operating under the names Bed Bath & Beyond (BBB), Christmas Tree Shops (CTS), Harmon and Harmon Face Values (Harmon) and buybuy BABY.
Related Categories
New CoverageStocks Mentioned
+0.37Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
